Joaquin Lado-Abeal

Joaquin Lado-Abeal

Auto-generated profile, based on publicly available information

Joaquin Lado-Abeal

Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, USA

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2005 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ADAlexandra M Dumitrescu
Alexandra M Dumitrescu
XLXiao-Hui Liao
Xiao-Hui Liao
MAMohamed S Y Abdullah
Mohamed S Y Abdullah
JLJoaquin Lado-Abeal
Joaquin Lado-Abeal
FMFathia Abdul Majed
Fathia Abdul Majed
SRSamuel Refetoff
Samuel Refetoff

8 October 2007 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
ARAlfonso Rodriguez‐Perez
Alfonso Rodriguez‐Perez
FPFernando Paz
Fernando Paz
EKEllen Kaptein
Ellen Kaptein
TVTheo J. Visser
Theo J. Visser
LDL. Dominguez‐Gerpe
L. Dominguez‐Gerpe
JLJoaquin Lado‐Abeal
Joaquin Lado‐Abeal

1 November 2008 in European Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
FPF Palos-Paz
F Palos-Paz
OPO Perez-Guerra
O Perez-Guerra
JCJ Cameselle-Teijeiro
J Cameselle-Teijeiro
CRC Rueda-Chimeno
C Rueda-Chimeno
FBF Barreiro-Morandeira
F Barreiro-Morandeira
BVB Victoria
B Victoria
Objective: Toxic thyroid adenoma (TA) is a common cause of hyperthyroidism. Mutations in the TSH receptor (TSHR) gene, and less frequently in the adenylate cyclase-stimulating G alpha protein (GNAS) gene, are well established causes of TA in Europe. However, genetic causes of TA remain unknown in a small percentage of cases. We report the first study to investigate mutations in TSHR, GNAS, protein kinase, cAMP-dependent, regulatory, type I alpha (PRKAR1A) and RAS genes, in a large series of TA from Galicia, an iodine-deficient region in NW Spain.Design and methods: Eighty-five TA samples were obtained surgically from 77 hyperthyroid patients, operated on for treatment of non-autoimmune toxic nodular goitre. After DNA extraction, all coding exons of TSHR, GNAS and PRKAR1A genes, and exons 2 and 3 of HRAS, KRAS and NRAS were amplified by PCR and sequenced. Previously unreported mutants were cloned in expression vectors and their basal constitutive activities were determined by quantification of cAMP response element (CRE)-luciferase activity in CO7 cells transfected with wild-type and mutant plasmids.Results: TSHR gene mutations were found in 52 (61.2%) samples, GNAS gene mutations in 4 (4.71%) samples and no PRKAR1A or RAS mutations were found. Only three previously unreported mutations were found, two affecting the TSHR, A623F and I635V, and one affecting the G-protein α-subunit (Gsα), L203P. All mutant proteins showed higher CRE-luciferase activity than their wild-type counterparts.Conclusions: TA in a hyperthyroid population living in Galicia, a Spanish iodine-deficient region, harbours elevated frequencies of TSHR and GNAS mutations activating the cAMP pathway. However, the genetic cause of TA was undetermined in 34% of the TA samples.

19 September 2008 in Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
David Araújo-VilarDavid Araújo-Vilar
David Araújo-Vilar
Giovanna LattanziGiovanna Lattanzi
Giovanna Lattanzi
BGB González-Méndez
B González-Méndez
ACA T Costa-Freitas
A T Costa-Freitas
DPD Prieto
D Prieto
JLJ Lado-Abeal
J Lado-Abeal
Background: Type 2 familial partial lipodystrophy (FPLD2) is characterised by loss of fat in the limbs and buttocks and results from mutations in the LMNA gene. Aim: To evaluate the role of several genes involved in adipogenesis in order to better understand the underlying mechanisms of regional loss of subcutaneous adipose tissue (scAT) in patients with FPLD2. Methods: In total, 7 patients with FPLD2 and 10 healthy control participants were studied. A minimal model was used to calculate the insulin sensitivity (IS). scAT was obtained from abdomen and thigh by biopsy. Relative gene expression was quantified by real-time reverse transcription PCR in a thermal cycler. Prelamin A western blot analysis was carried out on scAT and prelamin A nuclear localisation was determined using immunofluorescence. Adipocyte nuclei were examined by electron microscopy. Results: Patients with FPLD2 were found to have significantly lower IS. The expression of LMNA was similar in both groups. The expression of PPARG2, RB1, CCND3 and LPL in thigh but not in abdomen scAT was significantly reduced (67%, 25%, 38% and 66% respectively) in patients with FPLD2. Significantly higher levels of prelamin A were found in peripheral scAT of patients with FPLD2. Defects in the peripheral heterochromatin and a nuclear fibrous dense lamina were present in the adipocytes of patients with FPLD2. Conclusions: In FPLD2 participants, prelamin A accumulation in peripheral scAT is associated with a reduced expression of several genes involved in adipogenesis, which could perturb the balance between proliferation and differentiation in adipocytes, leading to less efficient tissue regeneration.

28 June 2008 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
DADavid Araújo‐Vilar
David Araújo‐Vilar
JLJoaquin Lado‐Abeal
Joaquin Lado‐Abeal
FPFernando Paz
Fernando Paz
Giovanna LattanziGiovanna Lattanzi
Giovanna Lattanzi
MBManuel A. Bandín
Manuel A. Bandín
ACAna Teresa Costa‐Freitas
Ana Teresa Costa‐Freitas

7 January 2013 in Journal of Molecular Endocrinology
Verified
Journal Article
Open access
PDF file
ICIsabel Castro
Isabel Castro
LQLeah Quisenberry
Leah Quisenberry
RCRosa-Maria Calvo
Rosa-Maria Calvo
MOMaria-Jesus Obregon
Maria-Jesus Obregon
JLJoaquin Lado-Abeal
Joaquin Lado-Abeal
Non-thyroidal illness syndrome (NTIS) is part of the neuroendocrine response to stress, but the significance of this syndrome remains uncertain. The aim of this study was to investigate the effect of lipopolysaccharide (LPS)-induced NTIS on thyroid hormone (TH) levels and TH molecular targets, as well as the relationship between septic shock nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) activation and TH receptor β (THRB) gene expression at a multi-tissue level in a pig model. Prepubertal domestic pigs were given i.v. saline or LPS for 48 h. Serum and tissue TH was measured by chemiluminescence and RIA. Expression of THRs and cofactors was measured by real-time PCR, and deiodinase (DIO) activity was measured by enzyme assays. Tissue NF-kB nuclear binding activity was evaluated by EMSA. LPS-treated pigs had decreased TH levels in serum and most tissues. DIO1 expression in liver and kidney and DIO1 activity in kidney decreased after LPS. No changes in DIO2 activity were observed between groups. LPS induced an increase in hypothalamus, thyroid, and liver DIO3 activity. Among the other studied genes, monocarboxylate transporter 8 and THRB were the most commonly repressed in endotoxemic pigs. LPS-induced NF-kB activation was associated with a decrease in THRB gene expression only in frontal lobe, adrenal gland, and kidney cortex. We conclude that LPS-induced NTIS in pigs is characterized by hypothyroidism and tissue-specific reduced TH sensitivity. The role of NF-kB in regulating THRB expression during endotoxemia, if any, is restricted to a limited number of tissues.